Fasiglifam (TAK-875) alters bile acid homeostasis in rats and dogs: a potential cause of drug induced liver injury-Reference-Cited by-同舟云学术

Fasiglifam (TAK-875) alters bile acid homeostasis in rats and dogs: a potential cause of drug induced liver injury

Published:2017-01-20 Issue: Volume: Page:kfx018
ISSN:1096-6080
Container-title:Toxicological Sciences
language:en
Short-container-title:Toxicol. Sci.

Author:

Wolenski Francis S.,Zhu Andy Z. X.,Johnson Mike,Yu Shaoxia,Moriya Yuu,Ebihara Takuya,Csizmadia Vilmos,Grieves Jessica,Paton Martin,Liao Mingxiang,Gemski Christopher,Pan Liping,Vakilynejad Majid,Dragan Yvonne P.,Chowdhury Swapan K.,Kirby Patrick J.

Publisher

Oxford University Press (OUP)

Subject

Toxicology

Link

http://academic.oup.com/toxsci/article-pdf/157/1/50/14173338/kfx018.pdf

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The GPR40 novel agonist SZZ15‐11 improves non‐alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet‐induced obese mice;Diabetes, Obesity and Metabolism;2024-03-18

2. Role of microsomal metabolism in bromfenac-induced cytotoxicity;Chemico-Biological Interactions;2024-03

3. First‐in‐human study of CPL207280, a novel G‐protein‐coupled receptor 40/free fatty acid receptor 1 agonist, in healthy volunteers after single and multiple administration;Diabetes, Obesity and Metabolism;2024-01-11

4. Preclinical evaluation of chemically reactive metabolites and mitigation of bioactivation in drug discovery;Drug Discovery Today;2023-07

5. Discovery of orally effective and safe GPR40 agonists by incorporating a chiral, rigid and polar sulfoxide into β-position to the carboxylic acid;European Journal of Medicinal Chemistry;2023-05